NVO

Novo-Nordisk A/S

D
NVO
USD
0.46
(0.3393%)
Market Closed
151,678.00
Volume
23.21
EPS
1.01
Div Yield
47.034
P/E
605,922,606,459.72
Market Cap
Today
0.3393%
1 Week
3.139%
1 Month
7.781%
6 Months
28.321%
12 Months
68.133%
Year To Date
31.465%
All Time
554.178%

Title:
Novo/Nordisk A/S

Sector:
Healthcare
Industry:
Biotechnology
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Do you need help or have a question?